The Insacog consortium conducting genomic sequencing has recommended a booster dose for those over 40, first targeting high-risk and high-exposure individuals, to bolster neutralising antibodies against Omicron. GoI must heed this advice. Because there’s no...
from Times of India Opinion https://ift.tt/3G9rYSs
from Times of India Opinion https://ift.tt/3G9rYSs
Post a Comment